SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Arterial Vascular Engineering AVEI -- Ignore unavailable to you. Want to Upgrade?

To: Walk Softly who wrote (199)5/17/1998 1:03:00 AM
From: Goolie2  Read Replies (1) | Respond to of 410
 
You don't want to forget BSX and their "next generation" stent comming soon. BTW, AVEI doesn't seem to troubled as they have competed against BSX in Europe successfully.

The chart looks like it is turning up; finally.

Goolie2@aol.com



To: Walk Softly who wrote (199)5/17/1998 12:53:00 PM
From: Dennis  Read Replies (1) | Respond to of 410
 
Craig, thanks for taking the time to post. I own MDT, they are getting out of the stent business. One less competitor to worry about.

AVEI was listed in IBD May 7 as one with a 5 year growth rate of at least 20% and expected earnings to more than double this year. Fiscal year ending June 30 expects earnings to soar 262%. Fourth year of higher earnings. Big short interest according to IBD. Any thoughts??

Good Luck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News